Stay updated on Safety, PK, and PD of FDL169 in CF - Clinical Trial

Sign up to get notified when there's something new on the Safety, PK, and PD of FDL169 in CF - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety, PK, and PD of FDL169 in CF - Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2 (previously v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:15:40.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A note was added that PubMed publications are automatically filled from PubMed and may not be about the study, and the revision is v3.3.1, while the prior PubMed note and older revision label v3.2.0 were removed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:20:08.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The notice about government funding lapse and NIH operating status was removed from the page.
    Difference
    0.4%
    Check dated 2025-11-17T06:26:51.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The screenshots show only minor cosmetic/layout differences with no changes to core information such as eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:12:06.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-05T09:56:36.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added version label v3.1.0 and removed multiple drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) along with an older revision reference (v3.0.2); content now omits several core safety sections. If these topics were critical, this is a notable reduction in coverage.
    Difference
    0.5%
    Check dated 2025-09-28T03:11:44.000Z thumbnail image

Stay in the know with updates to Safety, PK, and PD of FDL169 in CF - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety, PK, and PD of FDL169 in CF - Clinical Trial page.